Related references
Note: Only part of the references are listed.Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy
Jiping Zha et al.
CLINICAL CANCER RESEARCH (2010)
Rap1, a mercenary among the Ras-like GTPases
E. W. Frische et al.
DEVELOPMENTAL BIOLOGY (2010)
National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009
Carmen J. Allegra et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Karla Kerlikowske et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer
Robert E. Roses et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Loss of Rap1GAP in Papillary Thyroid Cancer
Anoma Nellore et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field
Henry M. Kuerer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The molecular journey from ductal carcinoma in situ to invasive breast cancer
Lisa Wiechmann et al.
CANCER (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells
Motonori Takahashi et al.
GENES TO CELLS (2008)
The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer
Danielle Lann et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
Jordi Rodon et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
P. Meijnen et al.
BRITISH JOURNAL OF SURGERY (2007)
Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells
Masahiko Itoh et al.
CANCER RESEARCH (2007)
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation
R. A. Jones et al.
ONCOGENE (2007)
Quantitative protein analysis from formalin-fixed tissues:: implications for translational clinical research and nanoscale molecular diagnosis
K-F Becker et al.
JOURNAL OF PATHOLOGY (2007)
Insulin-like growth factors control cell migration in health and disease
Marina A. Guvakova
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells
David Romano et al.
ENDOCRINOLOGY (2006)
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ
Lei Huo et al.
CANCER (2006)
Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins
S Paganini et al.
BIOCHIMIE (2006)
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer
LZ Zhang et al.
CANCER RESEARCH (2006)
Type I insulin-like growth factor receptor as a therapeutic target in cancer
BS Miller et al.
CANCER RESEARCH (2005)
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer:: The role of promoter methylation of TSC genes
WG Jiang et al.
EUROPEAN JOURNAL OF CANCER (2005)
Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes
H Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule, RAPL
T Kinashi et al.
IMMUNOLOGY LETTERS (2004)
Expression of insulin-like growth factor 1 receptor in primary breast cancer: Immunohistochemical analysis
C Shimizu et al.
HUMAN PATHOLOGY (2004)
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: Potential for intervention with 17-allylamino geldanamycin
TO Nielsen et al.
CANCER RESEARCH (2004)
Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers
T Hirata et al.
JOURNAL OF HUMAN GENETICS (2004)
Rap1 GTPase: Functions, regulation, and malignancy
M Hattori et al.
JOURNAL OF BIOCHEMISTRY (2003)
The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: Causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy
LE Hoorntje et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
DOCK4, a GTPase activator, is disrupted during tumorigenesis
V Yajnik et al.
CELL (2003)
Cellular functions of the Rap1 GTP-binding protein: a pattern emerges
E Caron
JOURNAL OF CELL SCIENCE (2003)
Inflammatory breast cancer - Relationship between growth factor signaling and motility in aggressive cancers
KL van Golen
BREAST CANCER RESEARCH (2003)
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
T Lopez et al.
CANCER CELL (2002)
Molecular alterations in ductal carcinoma in situ of the breast
K Polyak
CURRENT OPINION IN ONCOLOGY (2002)
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines
JG Jackson et al.
ONCOGENE (2001)
Rap1 signalling: Adhering to new models
JL Bos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Inhibition of the type 1 insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy
P Brodt et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences
FM Waldman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
